Pfizer and BioNTech start study to test combined COVID-19 and flu vaccine

By Abigail Adcox

Published November 3, 2022 2:15pm ET

Add Washington Examiner on Google

Pfizer and BioNTech start study to test combined COVID-19 and flu vaccine — FILE - In this Jan. 30, 2012 file photo, boxes of the drug Relpax, made by Pfizer, are displayed in Surfside, Fla. Pfizer reports quarterly results before the market open on Tuesday, Jan. 28, 2014. (AP Photo/Wilfredo Lee, File) | Wilfredo Lee

Pfizer and BioNTech announced Thursday they have begun an early-stage study to test a combination vaccine for COVID-19 and the flu.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 Pfizer research Vaccines